Literature DB >> 22022826

A review of candidate urinary biomarkers for autism spectrum disorder.

Lv Wang1, Manya T Angley, Jacobus P Gerber, Michael J Sorich.   

Abstract

CONTEXT: Autism is a complex, heterogeneous neurodevelopmental condition with a strong genetic component potentially impacted by various environmental factors influencing susceptibility. There are no reliable laboratory tests available to confirm an autism diagnosis.
OBJECTIVE: To examine the published literature and identify putative urinary biomarkers of autism.
METHODS: A comprehensive literature search was conducted using electronic bibliographic databases.
RESULTS: Putative autism biomarkers were identified that could be categorized according to the key theories that exist regarding the etiology of autism: gastrointestinal factors, immune dysregulation, heavy metal toxicity, neurotransmitter abnormalities, and oxidative stress.
CONCLUSION: There is scope for specific urinary biomarkers to be useful for identification of autistic metabolic phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22022826     DOI: 10.3109/1354750X.2011.598564

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  15 in total

1.  Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Authors:  Eman M Khaled; Nagwa A Meguid; Geir Bjørklund; Amr Gouda; Mohamed H Bahary; Adel Hashish; Nermin M Sallam; Salvatore Chirumbolo; Mona A El-Bana
Journal:  Metab Brain Dis       Date:  2016-07-13       Impact factor: 3.584

Review 2.  Gut microbiota-generated metabolites in animal health and disease.

Authors:  Won-Jae Lee; Koji Hase
Journal:  Nat Chem Biol       Date:  2014-06       Impact factor: 15.040

Review 3.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

Review 4.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

Review 5.  Autism biomarkers: challenges, pitfalls and possibilities.

Authors:  George M Anderson
Journal:  J Autism Dev Disord       Date:  2015-04

6.  Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers.

Authors:  Stewart F Graham; Onur Turkoglu; Ali Yilmaz; Ilyas Ustun; Zafer Ugur; Trent Bjorndhal; BeomSoo Han; Rupa Mandal; David Wishart; Ray O Bahado-Singh
Journal:  Metabolomics       Date:  2020-04-24       Impact factor: 4.290

7.  Longitudinal stability of salivary microRNA biomarkers in children and adolescents with autism spectrum disorder.

Authors:  David Levitskiy; Alexandra Confair; Kayla E Wagner; Samantha DeVita; Nicole Shea; Elizabeth P McKernan; Justin Kopec; Natalie Russo; Frank A Middleton; Steven D Hicks
Journal:  Res Autism Spectr Disord       Date:  2021-04-22

8.  Novel systems modeling methodology in comparative microbial metabolomics: identifying key enzymes and metabolites implicated in autism spectrum disorders.

Authors:  Colin Heberling; Prasad Dhurjati
Journal:  Int J Mol Sci       Date:  2015-04-22       Impact factor: 5.923

9.  The gut: a triggering place for autism - possibilities and challenges.

Authors:  Tore Midtvedt
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

Review 10.  Neurobiological abnormalities in the first few years of life in individuals later diagnosed with autism spectrum disorder: a review of recent data.

Authors:  C S Allely; C Gillberg; P Wilson
Journal:  Behav Neurol       Date:  2014-02-09       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.